Search Results - "Irtenkauf, Susan"
-
1
Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation
Published in Neoplasia (New York, N.Y.) (01-03-2014)“…Abstract The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early…”
Get full text
Journal Article -
2
Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research
Published in Comparative medicine (01-08-2017)“…Glioblastoma is an aggressive primary brain tumor predominantly localized to the cerebral cortex. We developed a panel of patient-derived mouse orthotopic…”
Get full text
Journal Article -
3
Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry
Published in Journal of visualized experiments (07-01-2014)“…Glioblastomas, the most common and aggressive form of astrocytoma, are refractory to therapy, and molecularly heterogeneous. The ability to establish cell…”
Get full text
Journal Article -
4
The impact of initial tumor microenvironment on imaging phenotype
Published in Cancer treatment and research communications (2021)“…•Most available murine models of glioblastoma (GBM) do not reproduce radiologic features of the human disease i.e., a space-occupying tumor and T1 contrast…”
Get full text
Journal Article -
5
Neurochemical changes after acute binge toluene inhalation in adolescent and adult rats: A high-resolution magnetic resonance spectroscopy study
Published in Neurotoxicology and teratology (01-11-2009)“…Abstract Inhalant abuse in young people is a growing public health concern. We reported previously that acute toluene intoxication in young rats, using a…”
Get full text
Journal Article -
6
EXTH-06. GLIOBLASTOMA PATIENT SPECIFIC TRANSCRIPTOME REMODELING IN RESPONSE TO MDM2 ANTAGONIST TREATMENT OF WILD-TYPE P53 CANCER STEM CELLS IS ASSOCIATED WITH SENSITIVITY AND STRATEGIES FOR COMBINATION THERAPY
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…Abstract Over 70% of glioblastomas are p53 wild-type and these patients could benefit from p53 reactivation treatment. Here we determined the sensitivity of a…”
Get full text
Journal Article -
7
CSIG-10. PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA ONCOGENE DEPENDENCY IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Abstract PDGFRA is the second most frequently amplified gene encoding receptor tyrosine kinase in adult glioblastoma (GBM), oftentimes as extrachromosomal…”
Get full text
Journal Article -
8
CSIG-06. PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA AS AN ONCOGENIC DRIVER IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)“…Abstract Activated platelet derived growth factor receptor alpha (PDGFRα) is essential for the maintenance of oligodendrocyte progenitors. Differential…”
Get full text
Journal Article -
9
Abstract 1505: Platelet derived growth factor receptor alpha oncogene dependency in glioblastoma
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Platelet-derived growth factor receptor alpha (PDGFRA) is a ligand-activated receptor tyrosine kinase (RTK) involved in neurodevelopment. In pediatric…”
Get full text
Journal Article -
10
Abstract 2519: Identification of novel MET fusion transcript amplification in glioblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Glioblastoma (GBM) is the most common and aggressive primary CNS malignant tumor with a 15.2% 2 year survival rate for tumors diagnosed between 2008…”
Get full text
Journal Article -
11
TMOD-06. HIGH INCIDENCE OF TUMORS AFTER TREATMENT WITH A DNA-ALKYLATING AGENT IN MOUSE STRAINS COMMONLY USED IN PRE-CLINICAL STUDIES
Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)“…Abstract Glioblastoma (GBM) is commonly treated with the DNA-alkylating agent temozolomide (TMZ). Silencing O6-methylguanine-DNA methyltransferase (MGMT) by…”
Get full text
Journal Article -
12
Abstract 3491: Heterogeneous extrachromosomal amplification of mutant PDGFRA is associated with an aggressive phenotype in glioblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Background & Objective: Receptor tyrosine kinase (RTK) signaling is altered in over 80% of glioblastoma (GBM) cases, frequently through gene…”
Get full text
Journal Article -
13
TMOD-36. DEVELOPMENT OF A PATIENT-DERIVED ORTHOTOPIC XENOGRAFT GLIOBLASTOMA MODEL PHENOTYPICALLY REPRESENTATIVE OF THE CLINICAL FEATURES
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2019)“…Abstract In murine models, patient derived orthotopic xenografts (PDOXs) generated from neurosphere cultures of human glioblastomas (GBMs) are unmatched in…”
Get full text
Journal Article -
14
Comparison of toluene-induced locomotor activity in four mouse strains
Published in Pharmacology, biochemistry and behavior (01-04-2010)“…The mechanisms by which abused inhalants exert their neurobehavioral effects are only partially understood. In research with other drugs of abuse, specific…”
Get full text
Journal Article -
15
Abstract 3860: Magnetization transfer and T2-weighted MRI studies are useful for visualizing phenotypic presentations of orthotopic, patient-derived xenograft mouse models of glioblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Introduction: Patient-derived xenograft (PDX) models for glioblastoma (GBM) from resected tumor tissues replicate several features of the original…”
Get full text
Journal Article -
16
Abstract 1755: TORK/DNA-PK inhibitor CC-115 is effective as a single agent in a subset of glioblastoma patient-derived cancer stem cells and xenografts and potentiates temozolomide therapy
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Glioblastoma (GBM) cells are highly invasive and respond poorly to radiation and chemotherapy. The mammalian target of rapamycin (mTOR), a…”
Get full text
Journal Article -
17
Abstract 628: A method to examine spatial relationships between tumor cells and vasculature using a mouse orthotopic PDX glioblastoma model
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Introduction: Glioblastoma progression requires angiogenesis and/or vascular co-option. A major pathway for its infiltration is the perivascular…”
Get full text
Journal Article -
18
Abstract 466: MR prediction of tumor burden in Patient-Derived Mouse Xenografts model of glioblastoma using an adaptive model
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Introduction: In human glioblastoma multiforme (GBM), infiltrating cells are found in remote locations, even in the hemisphere contralateral to the…”
Get full text
Journal Article -
19
Treatment of TBI with collagen scaffolds and human marrow stromal cells increases the expression of tissue plasminogen activator
Published in Journal of neurotrauma (01-07-2011)“…This study examines the effects of combination therapy of collagen scaffolds and human marrow stromal cells (hMSCs) on the expression of tissue plasminogen…”
Get more information
Journal Article -
20
Abstract 427: Sox2 modulation of cancer stem cell behavior in GBM
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Background and Objective: Glioblastoma (GBM) is the most aggressive primary brain tumor. GBM cells are phenotypically plastic and can present cancer…”
Get full text
Journal Article